Calcium kinetics and its intracellular mobilization are important in all biological processes. We used verapamil to examine the effect of calcium entry blockade on microvascular transport of macromolecules in ischemia-reperfusion injury. The rat cremaster muscle was splayed, placed in a Lucite intravital chamber, and suffused with bicarbonate buffer. The clearance of fluorescein isothiocyanate-conjugated dextran (FITC-dextran 150) was measured as an index of microvascular transport. After determination of baseline data (clearance of FITC-dextran 150, 3.0±0.5 ,1/5 min/g), the muscle was made ischemic for 2 hours by clamping its vascular pedicle and subsequently was reperfused for 2 hours. Ischemia-reperfusion produced a marked increase in FITC-dextran clearance. After a peak of 12±2-fold increase observed in the first 15 minutes into reperfusion, FITC-dextran 150 clearance decreased in magnitude and stabilized at about sixfold above baseline. Verapamil did not change the baseline clearance values. Importantly, verapamil inhibited the ischemia-induced increase in clearance and maintained the values at or near the baseline levels. We simultaneously determined the rate of release of 6-ketoprostaglandin F1, (6-keto-PGFIa) and thromboxane B2 (TXB2) into the suffusate. Verapamil decreased the baseline values of 6-keto-PGF1. and increased those of TXB2.
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Verapamil inhibited the ischemia-reperfusion-induced increase in 6-keto-PGFia but did not alter the effect of ischemia-reperfusion on TXB2. Our main results demonstrate the effectiveness of verapamil in preventing microvascular alterations leading to increased leakage of macromolecules. (Circulation Research 1990;66:1636-1642) C alcium entry blockade contributes to preserving myocardial function after ischemiareperfusion damage. Its mechanisms of protection include vasodilation, enhancement of collateral flow, and reduction of oxygen demand by stabilizing mitochondrial activity.1 Skeletal muscle, which has a metabolic rate lower than heart, can tolerate circulatory interruption for up to 6 hours without irreversible damage to the myocytes.2 However, microcirculatory derangements such as increased leakage of macromolecules and no reflow during reperfusion can occur in the rat cremaster muscle after only 30 minutes of ischemia. 3 Calcium kinetics and mobilization of intracellular calcium are important in every biological process. Influx of extracellular calcium is partially required for the activation of blood-formed elements,4 and it also produces an increase in microvascular permeability to macromolecules.5 Inflammatory mediators (e.g., bradykinin and histamine), which increase macromolecular transport through the endothelial barrier, are dependent on an influx of Ca2' ions into endothelial cells. Likewise, the early phase of ischemia-reperfusion syndrome is marked by an inflammatorylike response that includes microvascular leakage. Therefore, we tested the hypothesis that the increase in macromolecular clearance, induced by ischemia-reperfusion, may be partially explained by an influx of Ca2' into endothelial cells; or alternatively, there is an influx of Ca2' into tissues that regulates the endothelial barrier. We tested our hypothesis by administering verapamil, a calcium entry blocker.
Prostacyclin and thromboxane A2 also have been implicated in modulating vascular permeability. (Figure 1 ).
Ischemia-Reperfusion Protocol
One hour of baseline suffusate collection was followed by 2 hours of ischemia, which was achieved by cross-clamping the cremasteric pedicle with an atraumatic microvascular clamp. Verification of ischemia and reperfusion was obtained by intravital microscopy. After the ischemic period, circulation was reinstated for 2 hours by removal of the clamp. Suffusate flow was also stopped during ischemia and restarted during reperfusion. In separate time control studies, we established that the preparation remains stable at least 4 hours ( Table 1 ).
In the treated animals (n=5), verapamil (2.0 mg/ kg) was given as a 0.5-ml infusion over 10 minutes. This dose is effective in reducing ischemia-induced cardiac arrhythmias with transient effects on blood pressure and heart rate. (20 gl) were filled in duplicate and centrifuged. The plasma portion was transferred to a vial and diluted to 10 ml with saline. The concentration of FITC-dextran 150 in the plasma and suffusate was ascertained by using a Perkin-Elmer LS-3 spectrofluorometer (Norwalk, Conn.). A standard curve was constructed with known concentrations of FITC-dextran 150 ranging from 5.0 ng/ml to 2.0 ,ug/ml (see also Gawlowski and DuranlO).
The total extravasation of FITC-dextran 150 per 5 minutes and per gram wet tissue weight was evaluated for each suffusate sample. Figure 2 shows that plasma FITC-dextran 150 concentration fell linearly as a function of time over a period of 6 hours. The regression coefficient was 0.98; therefore, plasma concentrations were estimated for each collection by interpolation between two determinations. Our observations on plasma concentration decay confirm and extend those published earlier by Boric et al.8 Clearance (Cl) was calculated from the equation Cl=(S/P)(F/W), where S and P are the concentrations of FITC-dextran 150 in the suffusate and plasma, respectively, and F and W are suffusate flow rate and tissue wet weight. Cumulative clearance values for the respective experimental periods were assessed by adding the individual clearances over the appropriate time interval.8 
Analysis of Eicosanoids
Selected suffusate samples were analyzed by radioimmunoassay for 6-ketoprostaglandin F1,, (6-ketoPGF1a), the stable metabolite of prostacyclin, and for thromboxane B2 (TXB2), the stable metabolite of thromboxane A2. Lipid extractions were obtained by first acidifying 5 ml of suffusate to pH 3.5 with 4N formic acid and then extracting twice with equal volumes of ethyl acetate. The pooled solvent layers were evaporated to dryness under N2 and stored in 0.5 ml of radioimmunoassay buffer at -20°C.
Radioimmunoassays for TXB2 and 6-keto-PGFla were performed by using the method described by Reingold et al. 11 The lower limits of detection, defined as a 10% shift in labeled ligand binding, were 10 pg for 6-keto-PGFla, and 5 pg for TXB2. Interassay and intra-assay variances were less than 5% and 10%, respectively. The measured mass of prostanoids was expressed subsequently in terms of picograms per milliliter per minute to reflect the rate of their release into the suffusate.
Statistical Analysis Clearance data were calculated as microliters per 5 minutes per gram tissue wet weight. Group data are reported as mean±SEM. Clearances were measured before ischemia for baseline values, and they were also obtained continuously during reperfusion. The data from the control and verapamil-treated groups were compared in terms of the ratio of postischemic and preischemic values for every 15 minutes of reperfusion. A two-way analysis of variance was performed by categorizing the observations into 1) time of reperfusion and 2) treatment. Testing for least significant difference among the individual blocks was performed only if the F value was significant at 0.05.12 Results 
Intravital Microscopy
The microcirculation exhibited vigorous flow during the stabilization and equilibration periods. Cross- 9 clamping of the cremasteric vascular pedicle completely arrested the circulation. Upon reperfusion, blood flow began immediately. In the control animals, large aggregates of red blood cells and other elements that had dislodged were either washed into collecting venules or plugged small vessels further downstream. Large areas of no-reflow were seen after 2 hours of reperfusion, with aggregates clearly visible within the microscopic field. FITC-dextran 150 remained within the vessels during the preischemic period. Ischemia-reperfusion induced extravasation of fluorescent macromolecules, which was manifested by a generalized fluorescent field. This effect persisted for the 2 hours of reperfusion.
In all the animals tested, neither injection of the fluorochrome nor cross-clamping the cremasteric pedicle produced sustained changes in mean arterial pressure (98+5 mm Hg (Figure 2) .
In a separate set of experiments, we tested the stability of the preparation with regard to macromolecular transport. To this end, the clearance of FITCdextran 150 was determined continuously for 4 hours. Figure 3 . The statistical analysis of the effect of verapamil on macromolecular leakage is displayed in Table 2 . After 2 hours of ischemia, the macromolecular clearances of control animals increased immediately at reperfusion, with a maximal average increase of 11.9+2-fold observed within the first 15 minutes of reperfusion ( Figure 3 , Table 2 ). Subsequently, clearance values decreased in magnitude and remained at approximately sixfold above baseline for the remainder of the experiment. The clear- within 5 minutes of reperfusion ( Figure 5 ) and returned to preischemia values by 30 minutes of reperfusion. Administration of verapamil decreased the baseline values of 6-keto-PGFia and increased TXB2. One hour after verapamil, the average rate of release of 6-keto-PGFl, was 0.38±0.07 of the baseline values (Figure 4) . On the other hand, the average rate of release of TXB2 in the suffusate increased by 2.8+0.96-fold after verapamil injection ( Figure 5) .
Pretreatment with verapamil inhibited the rise in 6-keto-PGFla produced by ischemia-reperfusion. By 60 minutes of reperfusion, the rate of release of 6-keto-PGFia had returned to predrug and preischemia values (Figure 4 ). TXB2 release, which was elevated by the administration of verapamil, did not increase further after ischemia-reperfusion. The time course of the rate of TXB2 released into the suffusate was similar to that observed in the nontreated ischemia-reperfusion experiments ( Figure 5 ).
Discussion
Our main results support the hypothesis that calcium entry blockade, as produced by verapamil, protects against increases in microvascular leakage of macromolecules induced by ischemia-reperfusion injury. Pretreatment with verapamil maintained clearance of FITC-dextran 150 at or near preischemic levels during the reperfusion period.
Experimental Model
The exteriorized cremaster preparation was used because this model allows us to simultaneously measure extravasation of macromolecules, to evaluate microvascular alterations with intravital microscopy, and to collect samples for analysis of eicosanoids. The model also provides easy access to a common vascular pedicle and thus ensures the complete arrest of the microcirculation and the reproducibility of ischemia-reperfusion injury.
We analyzed suffusate samples as an index of the rate of synthesis/release of prostacyclin and thromboxane A2. The suffusate is contiguous with the interstitium. Thus, changes in eicosanoid levels in the suffusate reflect alterations in the entry rate of these compounds into that compartment. An advantage of the sampling technique is that it does not interfere with the circulation of the muscle. For our purposes, these determinations are adequate and satisfy our objective of determining simultaneously the release of eicosanoids and changes in leakage of macromolecules in the control and verapamil-treated rats.
Release of Eicosanoids
Our data did not show any clear correlation between eicosanoid level and macromolecular leakage in response to ischemia-reperfusion in either the control or verapamil-treated rats. Our results on basal and postischemic levels of 6-keto-PGFia and TXB2 do not support an important role for these two eicosanoids in modulating microvascular permselectivity after circulatory interruption. However, other investigators have proposed that prostacyclin and thromboxane modulate endothelial permeability in tissue cultures. 6 Intravenous verapamil affected baseline release of 6-keto-PGFla and TXB2 as well as their production in response to ischemia-reperfusion. Our observations are in general agreement with reports in which verapamil altered basal eicosanoid levels in different experimental models. Intravenous administration of verapamil to dogs decreased 6-keto-PGFia and slightly elevated TXB2 plasma levels. 13 In cardiac myocyte cultures, verapamil produced a biphasic dose response on prostaglandin 12 synthesis with doses of 10`7 M causing the greatest stimulation. At doses greater than and less than 10`' M, verapamil had either a submaximal or an inhibitory effect.14 Shunting of eicosanoid precursors or sensitivity of various tissues to calcium entry blockade may explain the divergent effect of intravenous verapamil on thromboxane and prostacyclin levels.15
Clearance of FITC-Dextran 150 Our control studies confirm previous work from our laboratory316"17 demonstrating that ischemia increases the clearance of macromolecules, which is immediately evident at reperfusion and lasts for at least 2 hours. Our control studies are in agreement with the observations that ischemia-reperfusion in the dog gracilis muscle decreases the osmotic reflection coefficient, as estimated by the isogravimetric technique. 18 In a separate study, we showed that the large initial peak of macromolecular clearance, observed at reperfusion, represents mainly washout of FITC-dextran 150 accumulated during the ischemic period.19 Therefore, we have based our conclusions about alterations of the microvascular barrier on the sustained elevated clearances observed after the first 15 minutes of reperfusion.
Clearance of macromolecules is dependent on microvascular surface area for transport, permselectivity of the barrier, convection, and diffusion. Changes Increases in microvascular permeability are thought to result from the release of a variety of inflammatory mediators, including histamine, bradykinin, plateletactivating factor, phospholipase-derived products, proteases, and free radicals. The origin of these substances appears to be the blood-formed elements.23 Activation of cellular processes that produce the aforementioned inflammatory mediators is partially controlled by the influx of extracellular calcium. Verapamil, a classic calcium entry blocker of voltagesensitive channels, also blocks leukotriene and superoxide production from granulocytes,4'24 histamineinduced vascular leakage,5'25 platelet aggregation,26'27 and platelet activating factor-induced edema.28 Proteases involved in superoxide and elastase release from granulocytes also require calcium.
Ischemia-reperfusion damage appears to be associated with a calcium influx into all affected cells. Benefits, therefore, may be derived from blocking the entry of calcium to these cells. Several studies have demonstrated that intravenous verapamil partially reduces calcium influx into 1) vascular smooth muscle to inhibit catecholamine-induced vasospasm,29 2) leukocytes to inhibit free radical and leukotriene synthesis, 3) red blood cells to inhibit crenation, 4) platelets to inhibit degranulation after reperfusion, 5) myocytes to reduce uncoupling of oxidative phosphorylation and to maintain cellular ATP, and 6) all cells containing calcium-dependent proteases and phospholipases to inhibit free radicals and lysophosphatide formation. Calcium entry blockade also has been shown to ameliorate vascular leakage in the isolated, perfused arrested heart model. 30 Interestingly, in the latter study, the perfusate was free of leukocytes and platelets, suggesting that the cause of the increased microvascular leakage permeability after ischemia-reperfusion may be by direct alteration of the endothelium. These observations support our hypothesis that the prevention of loss of endothelial permselectivity to macromolecules after ischemia-reperfusion is related to the ability of verapamil to block calcium entry to both microvascular and blood-formed elements.
Several agents have been shown to partially ameliorate the microvascular damage induced by ischemia-reperfusion. Substances 
